https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Grants Priority Review to Update Label for Sotatercept-Csrk

FDA Grants Priority Review to Update Label for Sotatercept-Csrk

Results from the ZENITH trial show sotatercept’s promise for pulmonary arterial hypertension treatment.

administrator

Related Articles